TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT04197596: Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Sponsor: New York Medical College · Phase: PHASE1/PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 40 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$967,725

Rescue Site Savings

+$645,150

Unlock Full NCT04197596 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04197596 Rescue Dossier →